1. Home
  2. RYZ vs DMRA Comparison

RYZ vs DMRA Comparison

Compare RYZ & DMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ryerson Holding Corporation Common Stock

RYZ

Ryerson Holding Corporation Common Stock

N/A

Current Price

$26.61

Market Cap

1.3B

Sector

Industrials

ML Signal

N/A

DMRA

Damora Therapeutics Inc. Common Stock

N/A

Current Price

$24.86

Market Cap

1.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RYZ
DMRA
Founded
1842
2011
Country
United States
United States
Employees
4300
7
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.5B
IPO Year
2014
2020

Fundamental Metrics

Financial Performance
Metric
RYZ
DMRA
Price
$26.61
$24.86
Analyst Decision
Hold
Buy
Analyst Count
1
2
Target Price
N/A
$43.00
AVG Volume (30 Days)
333.3K
290.2K
Earning Date
05-06-2026
05-11-2026
Dividend Yield
2.82%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$75.79
N/A
Revenue Next Year
$2.17
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$19.34
$16.50
52 Week High
$29.03
$28.76

Technical Indicators

Market Signals
Indicator
RYZ
DMRA
Relative Strength Index (RSI) 53.96 51.80
Support Level $23.60 $24.80
Resistance Level $29.03 $26.73
Average True Range (ATR) 1.38 1.53
MACD -0.17 0.05
Stochastic Oscillator 56.10 72.59

Price Performance

Historical Comparison
RYZ
DMRA

About RYZ Ryerson Holding Corporation Common Stock

Ryerson Holding Corp provides a metals service center, and value-added processor and is a distributor of industrial metals with operations in the United States, Canada, and Mexico. In addition to its North American operations, it conducts processing and distribution operations in China. It carries a full line of products in stainless steel, aluminum, carbon steel, and alloy steels and a limited line of nickel and red metals in various shapes and forms. The company has one operating and reportable segment, metals service centers. It derives substantially all of its sales from the processing and distribution of met. Geographically, the majority revenue is generated from the United States.

About DMRA Damora Therapeutics Inc. Common Stock

Damora Therapeutics Inc is a biotechnology company that aims to fundamentally redefine care for people with hematologic disorders. The group is advancing a new generation of biologics to treat mutant calreticulin-driven myeloproliferative neoplasms, including essential thrombocythemia and myelofibrosis, where there is cruicial medical need for disease-modifying treatments. Its goal is to rapidly bring forward optimized therapies with broad mutation coverage and exceptional convenience to dramatically improve patient outcomes. The group's pipeline products are DMR-001, DMR-002, DMR-003, and GB3226.

Share on Social Networks: